Table 1

Analysis of survival outcome in proband and sibling cohorts following different conditioning regimes, donor sources, and molecular diagnosis

Proband cohortMortalitySibling cohortMortalitySignificance (P)
Conditioning      
    Unconditioned 11 20 < .05* 
    RIC 20 < .05* 
    Myeloablative 12 18 NS 
Donor 
    MSD 11 NS 
    MFD < .05* 
    MUD NS 
    mMUD NS 
    Cord NS 
    Haplo 16 24 < .01* 
    GT-autologous NS 
Genetic defect 
    γ-c 10 14 < .01* 
    JAK3 NS 
    IL-7RA NS 
    RAG1/2 10 < .01* 
    Artemis NS 
    Omenn NS 
    ADA < .05* 
    Undefined 16 17 < .05* 
Proband cohortMortalitySibling cohortMortalitySignificance (P)
Conditioning      
    Unconditioned 11 20 < .05* 
    RIC 20 < .05* 
    Myeloablative 12 18 NS 
Donor 
    MSD 11 NS 
    MFD < .05* 
    MUD NS 
    mMUD NS 
    Cord NS 
    Haplo 16 24 < .01* 
    GT-autologous NS 
Genetic defect 
    γ-c 10 14 < .01* 
    JAK3 NS 
    IL-7RA NS 
    RAG1/2 10 < .01* 
    Artemis NS 
    Omenn NS 
    ADA < .05* 
    Undefined 16 17 < .05* 

RIC indicates reduced-intensity conditioning; MSD, matched sibling donor; MFD, matched family donor; MUD, matched unrelated donor; mMUD, mismatched unrelated donor; Cord, cord blood; Haplo, haploidentical; GT, gene therapy; ADA, adenosine deaminase; and NS, no statistical difference.

*

Statistically significant difference.

or Create an Account

Close Modal
Close Modal